Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,106 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

NCT01698905

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • USC Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Indiana Blood and Marrow Institute Beech Grove, Indiana, United States
  • St Agnes Hospital Baltimore, Maryland, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View all 62 locations
View Trial Details
Completed

Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)

NCT06648512

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, +10 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • FHRB (Finnish Hematology Registry and Clinical Biobank) Vantaa, Finland
  • Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Klinik für Hämatologie und Onkologie Berlin, Germany
View Trial Details
Completed

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

NCT02793544

Conditions
Acute Biphenotypic Leukemia (ABL), Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma, Acute Myelogenous Leukemia (AML), +26 more
Locations
  • Shands HealthCare & University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation

NCT04621851

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • McGill University - Jewish General Hospital Division of Hematology and Department of Oncology Montreal, Quebec, Canada
  • Charité University of Berlin - Clinic of Medicine - Hematology and Oncology Berlin, Germany
  • University of Mannheim, Mannheim, Germania Mannheim, Germany
  • ASST-Monza Monza, Italy/MB, Italy
View all 26 locations
View Trial Details

Related conditions